← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE

NDA · New Drug Application · Sponsor: CIPLA LTD · Approved 2012-10-16

Drug application

FDA Application #

NDA203076

Application type

New Drug Application

Brand name

LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE

Generic name

Lamivudine

Active ingredients

LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE

Dosage form

TABLET

Route

ORAL SUSPENSION

Marketing status

None (Tentative Approval)

Sponsor

CIPLA LTD

First approval

2012-10-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown